Skip to Content

Facebook picks David Ebersman as new CFO

NEW YORK (AP) – David Ebersman, a former executive at biotech firm Genentech, was named Monday as Facebook’s chief financial officer.

Ebersman, 39, will formally start at the Palo Alto, Calif.-based online hangout in September.

He replaces Gideon Yu, who left abruptly in March. Facebook said at the time it was looking for someone with “public company experience,” even though Yu had previously worked at Yahoo Inc. – which is public.

Ebersman hails from Genentech, which has been sold to pharmaceutical company Roche Holding AG.

“He was Genentech’s CFO while revenue tripled, and his success in scaling the finance organization of a fast-growing company will be important to Facebook,” founder and CEO Mark Zuckerberg said in a prepared statement.

Facebook, which turned 5 years old earlier this year, does not share specifics on its profitability because it is a privately held company. Research firm eMarketer, estimates that the company will reap $300 million in worldwide ad revenue this year, up 20 percent from 2008.

But Facebook has yet to turn a profit. In May, the company got a $200 million investment from Russian Internet investor Digital Sky Technologies. This valued Facebook at $10 billion and gave a nearly 2 percent stake in the company’s preferred stock.

Ebersman worked at Genentech for 15 years.

Keep Reading

Most Popular

This new data poisoning tool lets artists fight back against generative AI

The tool, called Nightshade, messes up training data in ways that could cause serious damage to image-generating AI models. 

Rogue superintelligence and merging with machines: Inside the mind of OpenAI’s chief scientist

An exclusive conversation with Ilya Sutskever on his fears for the future of AI and why they’ve made him change the focus of his life’s work.

Data analytics reveal real business value

Sophisticated analytics tools mine insights from data, optimizing operational processes across the enterprise.

The Biggest Questions: What is death?

New neuroscience is challenging our understanding of the dying process—bringing opportunities for the living.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.